Morbidity and mortality in schizophrenia with comorbid substance use disorders in Finland and Sweden

被引：1
|
作者：
Lahteenvuo, M. [1 ]
Batalla, A. [2 ]
Luykx, J. [3 ]
Mittendorfer-Rutz, E. [4 ]
Tanskanen, A. [4 ]
Tiihonen, J. [4 ]
Taipale, H. [4 ]
机构：
[1] Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio, Finland
[2] Univ Med Ctr Utrecht, Psychiat, Utrecht, Netherlands
[3] Univ Utrecht, Dept Psychiat, Utrecht, Netherlands
[4] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
来源：
EUROPEAN PSYCHIATRY | 2021年 / 64卷
关键词：
schizophrenia; substance abuse disorders; epidemiology; dual diagnosis;
D O I：
10.1192/j.eurpsy.2021.636
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0211
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [21] Management of comorbid anxiety and substance use disorders
    Myrick, H
    Brady, K
    [J]. PSYCHIATRIC ANNALS, 2001, 31 (04) : 265 - 271
  • [22] Comorbid Conduct Disorder and Substance Use Disorders
    Conner, Bradley T.
    Lochman, John E.
    [J]. CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE, 2010, 17 (04) : 337 - 349
  • [23] Major depression and comorbid substance use disorders
    Davis, Lori
    Uezato, Akihito
    Newell, Jason M.
    Frazier, Elizabeth
    [J]. CURRENT OPINION IN PSYCHIATRY, 2008, 21 (01) : 14 - 18
  • [24] Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
    Lahteenvuo, M.
    Luykx, J.
    Taipale, H.
    Mittendorfer-Rutz, E.
    Tanskanen, A.
    Batalla, A.
    Tiihonen, J.
    [J]. EUROPEAN PSYCHIATRY, 2021, 64 : S161 - S161
  • [25] Pharmacological treatment of schizophrenia with comorbid substance use disorder
    Azorin, Jean-Michel
    Simon, Nicolas
    Adida, Marc
    Belzeaux, Raoul
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (02) : 231 - 253
  • [26] Schizophrenia and comorbid substance use disorder: Effects of antipsychotics
    Green, AI
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 : 21 - 26
  • [27] Comparing violence in schizophrenia patients with and without comorbid substance-use disorders to community controls
    Short, T.
    Thomas, S.
    Mullen, P.
    Ogloff, J. R. P.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2013, 128 (04) : 306 - 313
  • [28] ILLNESS SEVERITY ASSOCIATED WITH COMORBID SUBSTANCE USE DISORDERS IN SCHIZOPHRENIA: AN ELECTRONIC HEALTH RECORD STUDY
    Patel, R.
    Chan, K. M. Y.
    Valko, M.
    Guruswamy, G.
    Ker, S.
    Batra, G.
    Kollins, S. h
    Renteria, M. E.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S465 - S465
  • [29] Long-Acting Injectable Antipsychotic Medications in Patients With Comorbid Schizophrenia and Substance Use Disorders
    Green, Alan I.
    [J]. JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (01) : 62 - 63
  • [30] A Primer on the Genetics of Comorbid Eating Disorders and Substance Use Disorders
    Munn-Chernoff, Melissa A.
    Baker, Jessica H.
    [J]. EUROPEAN EATING DISORDERS REVIEW, 2016, 24 (02) : 91 - 100
12345